Results 11 to 20 of about 23,777 (237)

Serial intrauterine transfusion for severe fetal anemia due to anti-M alloimmunization [PDF]

open access: yesAsian Journal of Transfusion Science
Anti-M antibody is one of the causes of severe fetal anemia and intrauterine death despite its relatively low frequency. A G3P2 26-year-old pregnant woman referred to our hospital at 29 weeks gestational age (WGA) with fetal hydrops. Her second pregnancy
Rachmat Dediat Kapnosa Hasani   +2 more
doaj   +2 more sources

Severe Hemolytic Disease of the Fetus Treated with Serial Intrauterine Transfusions: A Case Report and Review of Current Management [PDF]

open access: yesLife
Hemolytic disease of the fetus and newborn (HDFN) is a severe complication of pregnancy caused by maternal alloimmunization to fetal red blood cells, leading to significant perinatal morbidity and mortality.
Olga Olejniczak   +2 more
doaj   +2 more sources

Parvovirus: Conservative management of fetal anemia and hydrops [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica
Following the COVID‐19 pandemic, Northwestern Europe has experienced a marked increase in congenital parvovirus infections. This rise is attributed to social distancing measures which disrupted the usual seasonal variation of parvovirus B19.
Lyndsay Creswell   +8 more
doaj   +2 more sources

Radiofrequency Ablation and Intrauterine Transfusion in a Delayed Diagnosed Acardiac Twin Pregnancy. [PDF]

open access: goldCase Rep Obstet Gynecol, 2023
Rahimi-Sharbaf F   +9 more
europepmc   +3 more sources

Intrauterine blood transfusion [PDF]

open access: bronzeISBT Science Series, 2010
P. N. Adama van Scheltema, D. Oepkes
  +7 more sources

Heterozygous Beta‐Thalassaemia in Pregnancy: Two Rare Causes of Severe Fetal Anemia Requiring Intrauterine Blood Transfusions [PDF]

open access: hybridPrenatal Diagnosis, EarlyView.
ABSTRACT Aim In this article, we present two cases of severe fetal hemolytic anemia based on a beta‐thalassaemia trait inherited from a single parent. Results These cases, presented at 20 and 28 weeks' gestation, necessitated intra‐uterine blood transfusions.
Eva van der Meij   +11 more
openalex   +2 more sources

Short Neonatal Outcomes after Intrauterine Transfusion in Fetal Anemia, the Experience from a Referral Academic Center [PDF]

open access: yesIranian Journal of Neonatology, 2022
Background: Rhesus D-antibodies and maternal red blood cell alloimmunizations are the major causes of fetal anemia, which can cause hydrops and perinatal death if not treated through intrauterine intravascular blood transfusion (IUT).
Mahboobeh Shirazi   +7 more
doaj   +1 more source

Questioning universal use of O– red blood cells in intrauterine transfusions

open access: yesAJOG Global Reports, 2023
In the setting of maternal alloimmunization to antigen(s) on fetal red blood cells, significant fetal anemia may develop, and an intrauterine transfusion may be required. When selecting a blood product for intrauterine transfusion, the priority should be
Olivia G. Johnson, BS   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy